Karl W. Lauterbach, M.D., Sc.D., Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Services Misuse | 3 | 2005 | 243 | 0.490 |
Why?
|
Models, Econometric | 2 | 2005 | 218 | 0.470 |
Why?
|
Germany | 8 | 2005 | 862 | 0.410 |
Why?
|
National Health Programs | 2 | 2004 | 445 | 0.350 |
Why?
|
Guideline Adherence | 3 | 2005 | 2265 | 0.260 |
Why?
|
Dental Restoration Wear | 1 | 2005 | 7 | 0.260 |
Why?
|
Quality Assurance, Health Care | 3 | 2005 | 2211 | 0.260 |
Why?
|
Inlays | 1 | 2005 | 8 | 0.260 |
Why?
|
Evidence-Based Medicine | 4 | 2005 | 3608 | 0.250 |
Why?
|
Ethical Theory | 1 | 2003 | 34 | 0.230 |
Why?
|
Logic | 1 | 2003 | 39 | 0.220 |
Why?
|
Quality Indicators, Health Care | 3 | 2002 | 1831 | 0.220 |
Why?
|
Physicians, Family | 1 | 2005 | 345 | 0.220 |
Why?
|
Cost Savings | 2 | 2005 | 925 | 0.220 |
Why?
|
Technology Assessment, Biomedical | 1 | 2005 | 306 | 0.210 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2003 | 194 | 0.210 |
Why?
|
Cardiology Service, Hospital | 1 | 2003 | 246 | 0.200 |
Why?
|
Total Quality Management | 1 | 2002 | 274 | 0.190 |
Why?
|
Clinical Medicine | 1 | 2002 | 147 | 0.180 |
Why?
|
Health Services | 1 | 2005 | 758 | 0.180 |
Why?
|
Unnecessary Procedures | 1 | 2003 | 432 | 0.180 |
Why?
|
Education, Medical, Continuing | 1 | 2005 | 840 | 0.170 |
Why?
|
Diabetic Nephropathies | 2 | 2003 | 984 | 0.170 |
Why?
|
Antihypertensive Agents | 2 | 2005 | 2047 | 0.170 |
Why?
|
Benchmarking | 2 | 2003 | 1042 | 0.160 |
Why?
|
Health Services Research | 2 | 2003 | 1836 | 0.160 |
Why?
|
Hospital Administration | 1 | 2002 | 353 | 0.160 |
Why?
|
Primary Prevention | 1 | 2005 | 1167 | 0.150 |
Why?
|
Causality | 1 | 2003 | 1275 | 0.140 |
Why?
|
Drug Prescriptions | 1 | 2005 | 1636 | 0.130 |
Why?
|
Models, Theoretical | 2 | 2005 | 3587 | 0.120 |
Why?
|
Cost-Benefit Analysis | 5 | 2005 | 5388 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 3 | 2005 | 1683 | 0.120 |
Why?
|
Amitriptyline | 2 | 2004 | 110 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2003 | 1956 | 0.110 |
Why?
|
Terminal Care | 1 | 2005 | 1694 | 0.110 |
Why?
|
Disease Management | 1 | 2003 | 2459 | 0.110 |
Why?
|
Health Expenditures | 1 | 2005 | 2348 | 0.100 |
Why?
|
Hospitals | 2 | 2003 | 3953 | 0.100 |
Why?
|
Health Policy | 1 | 2003 | 2662 | 0.100 |
Why?
|
Citalopram | 2 | 2004 | 403 | 0.090 |
Why?
|
Biomedical Research | 1 | 2003 | 3308 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2004 | 4635 | 0.070 |
Why?
|
Practice Guidelines as Topic | 1 | 2003 | 7270 | 0.070 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2005 | 76 | 0.070 |
Why?
|
Physicians | 1 | 2002 | 4569 | 0.060 |
Why?
|
Philosophy, Medical | 1 | 2003 | 79 | 0.060 |
Why?
|
Social Welfare | 1 | 2003 | 87 | 0.050 |
Why?
|
Utilization Review | 1 | 2003 | 392 | 0.050 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2003 | 434 | 0.050 |
Why?
|
Treatment Refusal | 1 | 2004 | 421 | 0.050 |
Why?
|
Health Care Rationing | 1 | 2003 | 437 | 0.040 |
Why?
|
Models, Economic | 1 | 2004 | 712 | 0.040 |
Why?
|
Models, Statistical | 2 | 2005 | 5100 | 0.040 |
Why?
|
Health Resources | 1 | 2005 | 912 | 0.040 |
Why?
|
Social Justice | 1 | 2003 | 457 | 0.040 |
Why?
|
Health Care Costs | 2 | 2002 | 3207 | 0.040 |
Why?
|
Diabetic Foot | 1 | 2002 | 355 | 0.040 |
Why?
|
Endarterectomy, Carotid | 1 | 2003 | 546 | 0.040 |
Why?
|
Uncertainty | 1 | 2003 | 735 | 0.040 |
Why?
|
Program Evaluation | 2 | 2003 | 2483 | 0.040 |
Why?
|
Preventive Health Services | 1 | 2002 | 575 | 0.040 |
Why?
|
Efficiency, Organizational | 1 | 2002 | 695 | 0.040 |
Why?
|
Program Development | 1 | 2003 | 1314 | 0.040 |
Why?
|
Humans | 14 | 2005 | 743811 | 0.040 |
Why?
|
Drug Costs | 1 | 2004 | 1105 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2003 | 1874 | 0.030 |
Why?
|
Hypertension | 2 | 2005 | 8480 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6487 | 0.030 |
Why?
|
Patient Compliance | 1 | 2005 | 2683 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2003 | 2288 | 0.030 |
Why?
|
Diabetic Retinopathy | 1 | 2002 | 1211 | 0.030 |
Why?
|
Ambulatory Care | 1 | 2003 | 2707 | 0.030 |
Why?
|
Mammography | 1 | 2003 | 2475 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2004 | 2837 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2003 | 8637 | 0.020 |
Why?
|
Depressive Disorder | 1 | 2003 | 3744 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 6078 | 0.020 |
Why?
|
Primary Health Care | 1 | 2005 | 4556 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2002 | 3530 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 9944 | 0.020 |
Why?
|
Female | 5 | 2005 | 380020 | 0.020 |
Why?
|
Prevalence | 1 | 2005 | 15211 | 0.020 |
Why?
|
Aged | 3 | 2005 | 163178 | 0.020 |
Why?
|
Adolescent | 3 | 2005 | 85729 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14714 | 0.020 |
Why?
|
Medicare | 1 | 2005 | 6565 | 0.020 |
Why?
|
Adult | 4 | 2005 | 213889 | 0.020 |
Why?
|
Male | 4 | 2005 | 349776 | 0.020 |
Why?
|
Clinical Competence | 1 | 2002 | 4687 | 0.020 |
Why?
|
Stroke | 1 | 2005 | 9975 | 0.010 |
Why?
|
Middle Aged | 3 | 2005 | 213241 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2005 | 57744 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2002 | 11729 | 0.010 |
Why?
|
Risk Factors | 1 | 2005 | 72252 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 20827 | 0.010 |
Why?
|
Europe | 1 | 2002 | 3336 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2003 | 77410 | 0.010 |
Why?
|
Child, Preschool | 1 | 2002 | 40964 | 0.000 |
Why?
|
Child | 1 | 2002 | 77637 | 0.000 |
Why?
|